Creative Medical Technology Reports Pilot Results for Knee Osteoarthritis Treatment

Creative Medical Technology Holdings reported a 93% response rate and an approximately 65% reduction in group-average pain at six months in a 30-patient, open-label, single-arm pilot of Ultrasome for knee osteoarthritis.